Trial Outcomes & Findings for Telemonitoring of Patients With COPD in Carinthia (NCT NCT01580072)

NCT ID: NCT01580072

Last Updated: 2015-07-23

Results Overview

Baseline analyses and analyses after 12 months were conducted. Normal distribution is not given for SF-36 scales, means and Standard Deviation are reported. A high score defines a more favorable health state, items are scored on a 0 to 100 range. Scale scores represent the average for all items in the scale that the respondent answered.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

65 participants

Primary outcome timeframe

12 months

Results posted on

2015-07-23

Participant Flow

Due to organisational changes in the participating home nursing organisation and due to the age of the patients no nurse monitoring patients were admitted. Furthermore a first examination in the hospitals seemed to be hindering for these patients.

Participant milestones

Participant milestones
Measure
Control Group
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Overall Study
STARTED
28
37
0
Overall Study
COMPLETED
16
28
0
Overall Study
NOT COMPLETED
12
9
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Telemonitoring of Patients With COPD in Carinthia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=28 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=37 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Total
n=65 Participants
Total of all reporting groups
Age, Continuous
73.62 years
STANDARD_DEVIATION 10.28 • n=5 Participants
63.83 years
STANDARD_DEVIATION 7.69 • n=7 Participants
68.04 years
STANDARD_DEVIATION 8.80 • n=4 Participants
Gender
Female
10 participants
n=5 Participants
11 participants
n=7 Participants
21 participants
n=4 Participants
Gender
Male
18 participants
n=5 Participants
26 participants
n=7 Participants
44 participants
n=4 Participants
Region of Enrollment
Austria
28 participants
n=5 Participants
37 participants
n=7 Participants
65 participants
n=4 Participants

PRIMARY outcome

Timeframe: 12 months

Baseline analyses and analyses after 12 months were conducted. Normal distribution is not given for SF-36 scales, means and Standard Deviation are reported. A high score defines a more favorable health state, items are scored on a 0 to 100 range. Scale scores represent the average for all items in the scale that the respondent answered.

Outcome measures

Outcome measures
Measure
Control Group
n=16 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=28 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
physical functioning baseline
35.0 units on a scale
Standard Deviation 27.4
48.2 units on a scale
Standard Deviation 24.5
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
physical functioning after 12 months
22.8 units on a scale
Standard Deviation 15.4
39.8 units on a scale
Standard Deviation 31.5
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
role physical baseline
19.5 units on a scale
Standard Deviation 19.2
40.7 units on a scale
Standard Deviation 20.0
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
role physical after 12 months
28.9 units on a scale
Standard Deviation 20.9
35.9 units on a scale
Standard Deviation 25.0
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
bodily pain baseline
59.1 units on a scale
Standard Deviation 40.2
55.6 units on a scale
Standard Deviation 28.8
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
bodily pain after 12 months
52.8 units on a scale
Standard Deviation 39.1
55.3 units on a scale
Standard Deviation 32.6
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
general health baseline
40.1 units on a scale
Standard Deviation 26.7
49.3 units on a scale
Standard Deviation 14.4
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
general health after 12 months
36.3 units on a scale
Standard Deviation 21.3
47.3 units on a scale
Standard Deviation 25.1
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
vitality baseline
38.3 units on a scale
Standard Deviation 25.1
44.0 units on a scale
Standard Deviation 16.4
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
vitality after 12 months
35.5 units on a scale
Standard Deviation 22.4
44.6 units on a scale
Standard Deviation 27.9
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
social functioning baseline
58.6 units on a scale
Standard Deviation 36.7
67.4 units on a scale
Standard Deviation 24.4
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
social functioning after 12 months
64.1 units on a scale
Standard Deviation 36.8
61.2 units on a scale
Standard Deviation 33.9
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
role emotional baseline
27.6 units on a scale
Standard Deviation 28.7
53.4 units on a scale
Standard Deviation 28.8
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
role emotional after 12 months
45.8 units on a scale
Standard Deviation 29.0
53.7 units on a scale
Standard Deviation 33.6
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
mental health baseline
53.1 units on a scale
Standard Deviation 26.6
59.5 units on a scale
Standard Deviation 19.9
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
mental health after 12 months
56.6 units on a scale
Standard Deviation 27.8
59.6 units on a scale
Standard Deviation 26.7
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
physical component score baseline
35.3 units on a scale
Standard Deviation 11.3
38.1 units on a scale
Standard Deviation 7.6
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
physical component score after 12 months
31.0 units on a scale
Standard Deviation 9.2
36.1 units on a scale
Standard Deviation 10.3
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
mental component score baseline
35.0 units on a scale
Standard Deviation 13.1
41.8 units on a scale
Standard Deviation 11.7
Health Related Quality of Life as Measured by the Short-Form 36 Version 2 Questionnaire; The Short Form (36) Health Survey is a 36-item, Patient-reported Survey of Patient Health. The SF-36 is a Measure of Health Status.
mental component score after 12 months
41.0 units on a scale
Standard Deviation 14.6
42.7 units on a scale
Standard Deviation 14.8

PRIMARY outcome

Timeframe: 12 months

Outcome measures

Outcome measures
Measure
Control Group
n=28 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=37 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Number of Inpatient Stays
1.54 inpatient stays
Standard Deviation 2.27
1.16 inpatient stays
Standard Deviation 1.91

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome measures
Measure
Control Group
n=28 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=37 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Number of Bed Days for Hospitalised Patients
6.87 bed days
Standard Deviation 6.78
4.92 bed days
Standard Deviation 6.36

SECONDARY outcome

Timeframe: 12 months

Not all data were available, so only participants with consistent data were taken into comparison, this lead to a lower number of patients in this outcome measurement.

Outcome measures

Outcome measures
Measure
Control Group
n=19 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=30 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Number of Primary Care Visits
13.21 visits GP
Standard Deviation 10.27
9.67 visits GP
Standard Deviation 10.09

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome measures
Measure
Control Group
n=19 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=30 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Number of Specialist Visits
3.31 visits specialists
Standard Deviation 3.15
4.6 visits specialists
Standard Deviation 5.03

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome measures
Measure
Control Group
n=19 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=30 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
Number of Consultations of Emergency Doctor
0.79 consultations ED
Standard Deviation 1.03
1.17 consultations ED
Standard Deviation 2.42

SECONDARY outcome

Timeframe: 12 months

deceased patients in respect to participating patients, by obituary column

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

No data available

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months

The SGRQ is a 50-item questionnaire developed to measure health status (quality of life) in patients with diseases of airways obstruction. Scores are calculated for three domains: Symptoms, Activity and Impacts as well as a total score. Psychometric testing has demonstrated its repeatability, reliability and validity. Sensitivity has been demonstrated in clinical trials. A minimum change in score of 4 units was established as clinically relevant after patient and clinician testing. The SGRQ has been used in a range of disease groups including asthma, chronic obstructive pulmonary disease (COPD) and bronchiectasis, and in a range of settings such as randomised controlled therapy trials and population surveys.Due to missing data not all questoinnaires could be taken into consideration. Normal distribution is not given for SGRQ scales; Scores are expressed as a percentage of overall impairment where 100 represents worst possible health status and 0 indicates best pos

Outcome measures

Outcome measures
Measure
Control Group
n=16 Participants
Participants in the control group receive usual care.
Self Monitoring for Patients With COPD
n=25 Participants
self-monitoring for patients with severe COPD: Intervention Group entering vital parameters via Web Portal or automatic call center.
Nurse Monitoring for Patients With COPD
nurse-monitoring for patients with severe COPD: Nurses are entering vital parameters of the patient with mobile devices.
St. George's Respiratory Questionnaire SGRQ (Carinthia)
sympoms score baseline
74.0 units on a scale
Standard Deviation 20.1
69.0 units on a scale
Standard Deviation 18.0
St. George's Respiratory Questionnaire SGRQ (Carinthia)
sympoms score after 12 months
67.4 units on a scale
Standard Deviation 24.2
61.2 units on a scale
Standard Deviation 27.6
St. George's Respiratory Questionnaire SGRQ (Carinthia)
activity score baseline
76.3 units on a scale
Standard Deviation 17.2
68.9 units on a scale
Standard Deviation 22.9
St. George's Respiratory Questionnaire SGRQ (Carinthia)
activity score after 12 months
79.3 units on a scale
Standard Deviation 13.5
62.4 units on a scale
Standard Deviation 28.4
St. George's Respiratory Questionnaire SGRQ (Carinthia)
impacts score baseline
55.1 units on a scale
Standard Deviation 17.9
42.6 units on a scale
Standard Deviation 20.9
St. George's Respiratory Questionnaire SGRQ (Carinthia)
impacts score after 12 months
54.3 units on a scale
Standard Deviation 20.1
42.3 units on a scale
Standard Deviation 23.3
St. George's Respiratory Questionnaire SGRQ (Carinthia)
total score baseline
64.8 units on a scale
Standard Deviation 15.3
54.6 units on a scale
Standard Deviation 18.1
St. George's Respiratory Questionnaire SGRQ (Carinthia)
total score after 12 months
64.2 units on a scale
Standard Deviation 17.7
50.8 units on a scale
Standard Deviation 24.0

SECONDARY outcome

Timeframe: 12 months

Outcome measures

Outcome data not reported

Adverse Events

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Self Monitoring for Patients With COPD

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Nurse Monitoring for Patients With COPD

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Hannes Steinberger

Landeskrankenanstalten-Betriebsgesellschaft

Phone: +4346355212 50303

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place